Zacks Investment Research
News Agency

Surging Earnings Estimates Signal Upside for Protagonist Therapeutics (PTGX) Stock
Protagonist Therapeutics (PTGX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Related Symbols
1
P
PTGX
PTGX
Source:
Zacks Investment Research
Visit Source
Comments